Health ❯ Healthcare ❯ Clinical Trials ❯ Drug Efficacy

Cognitive Decline

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

The newly approved antibody therapy targets amyloid plaques to slow cognitive decline in select patients.

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs